To elucidate the mechanism of action (MoA) of ceritinib’s antiproliferative activity in these cells, we applied a systems approach combining both chemical and phosphoproteomics to gain a global view of ceritinib’s target profile and network-wide phosphorylation changes following ceritinib treatment.
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: Chemical proteomics ; phosphoproteomics
|
Principal Investigators: (in alphabetical order) |
Uwe Rix, Moffitt Cancer Center, N/A |
| Submitting User: | ccms |
Kuenzi BM, Remsing Rix LL, Stewart PA, Fang B, Kinose F, Bryant AT, Boyle TA, Koomen JM, Haura EB, Rix U.
Polypharmacology-based ceritinib repurposing using integrated functional proteomics.
Nat. Chem. Biol. 2017 Dec;13(12):1222-1231. Epub 2017 Oct 9.
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | Browse Results |
|
FTP Download Link (click to copy):
|
|